Transcatheter Aortic Valve Replacement for Aortic Regurgitation in Patients with Left Ventricular Assist Devices: An Institutional Experience
TAVR for AR in selected patients with LVAD is a feasible therapeutic option that may improve outcomes. Larger studies are necessary to better define procedural risks, optimal patient selection, and the role of TAVR valves specifically designed for AR in this population.
Authors
- Hanad Bashir (ORCID: https://orcid.org/0000-0002-7783-8966)
- Nadia El‐Hangouche
- Puvi Seshiah (ORCID: https://orcid.org/0009-0007-3192-3878)
- Christian W. Schmidt (ORCID: https://orcid.org/0000-0002-9333-1620)
- Raviteja Reddy Guddeti (ORCID: https://orcid.org/0000-0001-8740-2501)
- Gregory F. Egnaczyk (ORCID: https://orcid.org/0000-0002-1909-2334)
- Santiago A. Garcia (ORCID: https://orcid.org/0000-0002-1806-6783)
- Dean J. Kereiakes (ORCID: https://orcid.org/0000-0003-1086-127X)
- Alan Wong (ORCID: https://orcid.org/0000-0002-0552-3922)
- Janelle Muuse
- Gustavo Méndez-Hirata (ORCID: https://orcid.org/0009-0000-1251-7339)
Institutions
- Christ Hospital (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.jscai.2025.103662
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67